BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20819668)

  • 1. Up-regulation of the expression of S100A8 and S100A9 in lung adenocarcinoma and its correlation with inflammation and other clinical features.
    Su YJ; Xu F; Yu JP; Yue DS; Ren XB; Wang CL
    Chin Med J (Engl); 2010 Aug; 123(16):2215-20. PubMed ID: 20819668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
    Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
    Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.
    Leukert N; Vogl T; Strupat K; Reichelt R; Sorg C; Roth J
    J Mol Biol; 2006 Jun; 359(4):961-72. PubMed ID: 16690079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant.
    Nacken W; Kerkhoff C
    FEBS Lett; 2007 Oct; 581(26):5127-30. PubMed ID: 17936757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity.
    Nacken W; Roth J; Sorg C; Kerkhoff C
    Microsc Res Tech; 2003 Apr; 60(6):569-80. PubMed ID: 12645005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-associated S100 proteins: new mechanisms that regulate function.
    Goyette J; Geczy CL
    Amino Acids; 2011 Oct; 41(4):821-42. PubMed ID: 20213444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A8 and S100A9 in inflammation and cancer.
    Gebhardt C; Németh J; Angel P; Hess J
    Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma.
    Choi JH; Shin NR; Moon HJ; Kwon CH; Kim GH; Song GA; Jeon TY; Kim DH; Kim DH; Park DY
    Histol Histopathol; 2012 Nov; 27(11):1439-48. PubMed ID: 23018243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value.
    Eikmans M; Roos-van Groningen MC; Sijpkens YW; Ehrchen J; Roth J; Baelde HJ; Bajema IM; de Fijter JW; de Heer E; Bruijn JA
    J Am Soc Nephrol; 2005 Dec; 16(12):3771-86. PubMed ID: 16251238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct roles for S100a8 in early embryo development and in the maternal deciduum.
    Baker JR; Jeffery R; May RD; Mathies M; Spencer-Dene B; Poulsom R; Hogg N
    Dev Dyn; 2011 Sep; 240(9):2194-203. PubMed ID: 22016186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14).
    Leukert N; Sorg C; Roth J
    Biol Chem; 2005 May; 386(5):429-34. PubMed ID: 15927886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.
    Ehrchen JM; Sunderkötter C; Foell D; Vogl T; Roth J
    J Leukoc Biol; 2009 Sep; 86(3):557-66. PubMed ID: 19451397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis.
    Hiratsuka S; Watanabe A; Aburatani H; Maru Y
    Nat Cell Biol; 2006 Dec; 8(12):1369-75. PubMed ID: 17128264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
    Grebhardt S; Veltkamp C; Ströbel P; Mayer D
    Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA.
    Endoh Y; Chung YM; Clark IA; Geczy CL; Hsu K
    J Immunol; 2009 Feb; 182(4):2258-68. PubMed ID: 19201880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
    Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
    Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin.
    Lee Y; Jang S; Min JK; Lee K; Sohn KC; Lim JS; Im M; Lee HE; Seo YJ; Kim CD; Lee JH
    Biochem Biophys Res Commun; 2012 Jul; 423(4):647-53. PubMed ID: 22683330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide.
    Henke MO; Renner A; Rubin BK; Gyves JI; Lorenz E; Koo JS
    Exp Lung Res; 2006 Sep; 32(8):331-47. PubMed ID: 17090475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
    Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
    J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis.
    Ghavami S; Chitayat S; Hashemi M; Eshraghi M; Chazin WJ; Halayko AJ; Kerkhoff C
    Eur J Pharmacol; 2009 Dec; 625(1-3):73-83. PubMed ID: 19835859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.